Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Trichosanthin (TCS) is a type I ribosome-inactivating protein with potent inhibitory activity against human immunodeficiency virus type 1. However, the anti-viral mechanism remains elusive. By a well-accepted HIV-1 integration assay, we demonstrated that TCS prevents HIV-1 DNA integration in a dose dependent manner in cell culture. At the same condition, TCS fails to induce obvious cytotoxicity and is also unable to interference viral early events such as viral entry, uncoating or reverse transcription. The HIV-1
integrase
can integrate HIV-1 long-terminal repeats into cellular chromosome. The interaction of TCS with these viral integration components was also examined, indicating that TCS does not interact with HIV-1
integrase
by the
GST
-pull down assay, but binds to the long terminal repeats in a transient manner. We further revealed that TCS can efficiently depurinate HIV-1 long-terminal repeats, which may be responsible for the inhibitory activity on HIV-1 integration. In conclusion, we elucidated that TCS specifically inhibits HIV-1 integration by depurinating the long-terminal repeats.
...
PMID:Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats. 1966 33
Conventionally, expression plasmids in Escherichia coli have generally been constructed using ligation reaction-assisted cloning followed by the generation of inserts. In such cases, the insert was generated by polymerase chain reaction (PCR), digestion using restriction enzymes, or oligonucleotide synthesis. To overcome the restrictions of these conventional methods, we improved them by utilizing an in vitro site-specific recombination reaction, based on the
integrase
-excisionase system of bacteriophage lambda to insert DNA fragments. This method enabled us to insert tens of fragments into expression vectors in parallel. We applied these methods to produce
glutathione S-transferase
(
GST
)-fused or maltose-binding protein (MBP)-fused proteins in Escherichia coli. As a result, we successfully produced and purified more than 3,000 recombinant proteins for further study of reverse chemical genetics.
...
PMID:High-throughput production of the recombinant proteins expressed in Escherichia coli utilizing cDNA resources. 1971 10
We have previously shown that, in vivo, the integration system based on the gene encoding the TG1
integrase
and the corresponding attB (TG1) and attP (TG1) sites works well not only in Streptomyces strains, but also in Escherichia coli. Furthermore, the attachment sites for TG1
integrase
are distinct from those of phi C31
integrase
. In this report, we expressed TG1
integrase
as a
GST
-TG1
integrase
fusion protein and then used affinity separation and specific cleavage to release purified
integrase
. Conditions for in vitro recombination were established using the purified TG1
integrase
and its cognate attP (TG1) and attB (TG1) sites. TG1
integrase
efficiently catalyzed a site-specific recombination between attB (TG1) and attP (TG1) sites irrespective of their substrate topology. The minimal sequences of attP (TG1) and attB (TG1) sites required for the substrates of TG1
integrase
were demonstrated to be 43 and 39-bp, respectively. These results provide the basic features of the TG1
integrase
system to be used as biotechnological tools, as well as to unravel the mechanism of the serine
integrase
.
...
PMID:In vitro characterization of the site-specific recombination system based on actinophage TG1 integrase. 1983 41
The retroviral
integrase
plays an essential role in the integration of reverse-transcribed retroviral cDNA into the host cell genome, and serves as an important target for anti-viral therapeutics. In this study, we identified the COP9 signalosome subunit 6 (CSN6) as a novel avian leukosis virus (ALV)
integrase
binding protein. Co-immunoprecipitation and
GST
pull-down assays showed that CSN6 bound to ALV
integrase
likely through direct interaction of CSN6 to the catalytic core of the
integrase
. We further demonstrated CSN6 inhibited
integrase
activity in vitro; knockdown of CSN6 in DF-1 promoted ALV production. These results indicated that CSN6 may be a negative regulator of ALV replication by binding to and inhibiting
integrase
. Our findings provided the insight into the
integrase
-based host defense system and may have implications in the development of
integrase
-based anti-viral strategies.
...
PMID:COP9 signalosome subunit 6 binds and inhibits avian leukosis virus integrase. 2528 39
<< Previous
1
2